nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—Hydrocortisone—systemic lupus erythematosus	0.319	1	CrCtD
Drospirenone—PTGS2—systemic lupus erythematosus	0.102	1	CbGaD
Drospirenone—NR3C2—Betamethasone—systemic lupus erythematosus	0.0512	0.204	CbGbCtD
Drospirenone—NR3C2—Prednisolone—systemic lupus erythematosus	0.0505	0.202	CbGbCtD
Drospirenone—PGR—Betamethasone—systemic lupus erythematosus	0.0331	0.132	CbGbCtD
Drospirenone—NR3C2—Dexamethasone—systemic lupus erythematosus	0.0298	0.119	CbGbCtD
Drospirenone—PGR—Dexamethasone—systemic lupus erythematosus	0.0192	0.0767	CbGbCtD
Drospirenone—BCHE—Triamcinolone—systemic lupus erythematosus	0.0181	0.0721	CbGbCtD
Drospirenone—PTGS2—Dapsone—systemic lupus erythematosus	0.016	0.0639	CbGbCtD
Drospirenone—PTGS2—Triamcinolone—systemic lupus erythematosus	0.0139	0.0554	CbGbCtD
Drospirenone—Eplerenone—Hydrocortisone—systemic lupus erythematosus	0.0125	0.0459	CrCrCtD
Drospirenone—PTGS2—Betamethasone—systemic lupus erythematosus	0.0119	0.0476	CbGbCtD
Drospirenone—Formestane—Hydrocortisone—systemic lupus erythematosus	0.0105	0.0384	CrCrCtD
Drospirenone—Potassium Canrenoate—Hydrocortisone—systemic lupus erythematosus	0.00947	0.0347	CrCrCtD
Drospirenone—Spironolactone—Hydrocortisone—systemic lupus erythematosus	0.00947	0.0347	CrCrCtD
Drospirenone—Megestrol acetate—Hydrocortisone—systemic lupus erythematosus	0.00866	0.0318	CrCrCtD
Drospirenone—Potassium Canrenoate—Prednisone—systemic lupus erythematosus	0.00815	0.0299	CrCrCtD
Drospirenone—Medrysone—Hydrocortisone—systemic lupus erythematosus	0.00799	0.0293	CrCrCtD
Drospirenone—Potassium Canrenoate—Prednisolone—systemic lupus erythematosus	0.00796	0.0292	CrCrCtD
Drospirenone—Medroxyprogesterone Acetate—Hydrocortisone—systemic lupus erythematosus	0.0077	0.0283	CrCrCtD
Drospirenone—Medrysone—Methylprednisolone—systemic lupus erythematosus	0.00754	0.0277	CrCrCtD
Drospirenone—Flurandrenolide—Hydrocortisone—systemic lupus erythematosus	0.00743	0.0273	CrCrCtD
Drospirenone—Medroxyprogesterone Acetate—Methylprednisolone—systemic lupus erythematosus	0.00727	0.0267	CrCrCtD
Drospirenone—Flurandrenolide—Methylprednisolone—systemic lupus erythematosus	0.00701	0.0257	CrCrCtD
Drospirenone—Norethindrone—Hydrocortisone—systemic lupus erythematosus	0.00695	0.0255	CrCrCtD
Drospirenone—PTGS2—Dexamethasone—systemic lupus erythematosus	0.00694	0.0277	CbGbCtD
Drospirenone—Flurandrenolide—Dexamethasone—systemic lupus erythematosus	0.0069	0.0253	CrCrCtD
Drospirenone—Flurandrenolide—Betamethasone—systemic lupus erythematosus	0.0069	0.0253	CrCrCtD
Drospirenone—Cortisone acetate—Hydrocortisone—systemic lupus erythematosus	0.00674	0.0247	CrCrCtD
Drospirenone—Medrysone—Prednisolone—systemic lupus erythematosus	0.00672	0.0247	CrCrCtD
Drospirenone—Cortisone acetate—Methylprednisolone—systemic lupus erythematosus	0.00636	0.0233	CrCrCtD
Drospirenone—Flurandrenolide—Prednisolone—systemic lupus erythematosus	0.00625	0.0229	CrCrCtD
Drospirenone—Testolactone—Methylprednisolone—systemic lupus erythematosus	0.00617	0.0226	CrCrCtD
Drospirenone—Testolactone—Betamethasone—systemic lupus erythematosus	0.00607	0.0223	CrCrCtD
Drospirenone—Testolactone—Dexamethasone—systemic lupus erythematosus	0.00607	0.0223	CrCrCtD
Drospirenone—Testolactone—Triamcinolone—systemic lupus erythematosus	0.00593	0.0218	CrCrCtD
Drospirenone—Progesterone—Hydrocortisone—systemic lupus erythematosus	0.00585	0.0215	CrCrCtD
Drospirenone—Testosterone Propionate—Hydrocortisone—systemic lupus erythematosus	0.00585	0.0215	CrCrCtD
Drospirenone—Cortisone acetate—Prednisone—systemic lupus erythematosus	0.0058	0.0213	CrCrCtD
Drospirenone—Methyltestosterone—Hydrocortisone—systemic lupus erythematosus	0.00571	0.0209	CrCrCtD
Drospirenone—Cortisone acetate—Prednisolone—systemic lupus erythematosus	0.00566	0.0208	CrCrCtD
Drospirenone—Testolactone—Prednisone—systemic lupus erythematosus	0.00563	0.0207	CrCrCtD
Drospirenone—Testolactone—Prednisolone—systemic lupus erythematosus	0.0055	0.0202	CrCrCtD
Drospirenone—Testosterone—Hydrocortisone—systemic lupus erythematosus	0.00508	0.0186	CrCrCtD
Drospirenone—Progesterone—Prednisolone—systemic lupus erythematosus	0.00492	0.0181	CrCrCtD
Drospirenone—Methyltestosterone—Prednisone—systemic lupus erythematosus	0.00492	0.018	CrCrCtD
Drospirenone—Methyltestosterone—Prednisolone—systemic lupus erythematosus	0.0048	0.0176	CrCrCtD
Drospirenone—Hydrocortisone—Methylprednisolone—systemic lupus erythematosus	0.00451	0.0165	CrCrCtD
Drospirenone—Hydrocortisone—Betamethasone—systemic lupus erythematosus	0.00443	0.0163	CrCrCtD
Drospirenone—Hydrocortisone—Dexamethasone—systemic lupus erythematosus	0.00443	0.0163	CrCrCtD
Drospirenone—Hydrocortisone—Triamcinolone—systemic lupus erythematosus	0.00433	0.0159	CrCrCtD
Drospirenone—Testosterone—Prednisolone—systemic lupus erythematosus	0.00427	0.0157	CrCrCtD
Drospirenone—Hydrocortisone—Prednisone—systemic lupus erythematosus	0.00411	0.0151	CrCrCtD
Drospirenone—Hydrocortisone—Prednisolone—systemic lupus erythematosus	0.00401	0.0147	CrCrCtD
Drospirenone—BCHE—diaphragm—systemic lupus erythematosus	0.0029	0.196	CbGeAlD
Drospirenone—NR3C2—blood plasma—systemic lupus erythematosus	0.000909	0.0613	CbGeAlD
Drospirenone—Infarction—Methylprednisolone—systemic lupus erythematosus	0.000816	0.0322	CcSEcCtD
Drospirenone—Uterine haemorrhage—Cyclosporine—systemic lupus erythematosus	0.000776	0.0306	CcSEcCtD
Drospirenone—Thromboembolic event—Methotrexate—systemic lupus erythematosus	0.000557	0.0219	CcSEcCtD
Drospirenone—BCHE—blood plasma—systemic lupus erythematosus	0.000548	0.0369	CbGeAlD
Drospirenone—Embolism venous—Prednisolone—systemic lupus erythematosus	0.000489	0.0193	CcSEcCtD
Drospirenone—NR3C2—connective tissue—systemic lupus erythematosus	0.000484	0.0326	CbGeAlD
Drospirenone—Embolism venous—Hydrocortisone—systemic lupus erythematosus	0.000478	0.0188	CcSEcCtD
Drospirenone—PTGS2—endothelium—systemic lupus erythematosus	0.000475	0.032	CbGeAlD
Drospirenone—NR3C2—nephron tubule—systemic lupus erythematosus	0.000469	0.0316	CbGeAlD
Drospirenone—PGR—connective tissue—systemic lupus erythematosus	0.00045	0.0303	CbGeAlD
Drospirenone—Embolism venous—Triamcinolone—systemic lupus erythematosus	0.00045	0.0177	CcSEcCtD
Drospirenone—Embolism venous—Methylprednisolone—systemic lupus erythematosus	0.000449	0.0177	CcSEcCtD
Drospirenone—PTGS2—blood plasma—systemic lupus erythematosus	0.000422	0.0285	CbGeAlD
Drospirenone—NR3C2—kidney—systemic lupus erythematosus	0.000412	0.0278	CbGeAlD
Drospirenone—Embolism venous—Dexamethasone—systemic lupus erythematosus	0.000408	0.0161	CcSEcCtD
Drospirenone—Embolism venous—Betamethasone—systemic lupus erythematosus	0.000408	0.0161	CcSEcCtD
Drospirenone—NR3C2—cortex of kidney—systemic lupus erythematosus	0.000401	0.0271	CbGeAlD
Drospirenone—Embolism—Prednisolone—systemic lupus erythematosus	0.000384	0.0152	CcSEcCtD
Drospirenone—Thrombosis—Cyclosporine—systemic lupus erythematosus	0.000383	0.0151	CcSEcCtD
Drospirenone—Embolism—Hydrocortisone—systemic lupus erythematosus	0.000376	0.0148	CcSEcCtD
Drospirenone—Thrombosis—Mycophenolate mofetil—systemic lupus erythematosus	0.000374	0.0147	CcSEcCtD
Drospirenone—AR—connective tissue—systemic lupus erythematosus	0.000359	0.0242	CbGeAlD
Drospirenone—Embolism venous—Prednisone—systemic lupus erythematosus	0.000355	0.014	CcSEcCtD
Drospirenone—Embolism—Triamcinolone—systemic lupus erythematosus	0.000354	0.0139	CcSEcCtD
Drospirenone—Embolism—Methylprednisolone—systemic lupus erythematosus	0.000353	0.0139	CcSEcCtD
Drospirenone—NR3C2—tendon—systemic lupus erythematosus	0.000333	0.0224	CbGeAlD
Drospirenone—PGR—lymphoid tissue—systemic lupus erythematosus	0.000329	0.0222	CbGeAlD
Drospirenone—Loss of libido—Methotrexate—systemic lupus erythematosus	0.000325	0.0128	CcSEcCtD
Drospirenone—AR—skin of body—systemic lupus erythematosus	0.000324	0.0218	CbGeAlD
Drospirenone—Embolism—Dexamethasone—systemic lupus erythematosus	0.000321	0.0126	CcSEcCtD
Drospirenone—Embolism—Betamethasone—systemic lupus erythematosus	0.000321	0.0126	CcSEcCtD
Drospirenone—Breast pain—Cyclosporine—systemic lupus erythematosus	0.000311	0.0123	CcSEcCtD
Drospirenone—AR—kidney—systemic lupus erythematosus	0.000305	0.0206	CbGeAlD
Drospirenone—Breast pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000303	0.012	CcSEcCtD
Drospirenone—AR—cortex of kidney—systemic lupus erythematosus	0.000297	0.02	CbGeAlD
Drospirenone—NR3C2—lung—systemic lupus erythematosus	0.000292	0.0197	CbGeAlD
Drospirenone—BCHE—nephron tubule—systemic lupus erythematosus	0.000283	0.0191	CbGeAlD
Drospirenone—Embolism—Prednisone—systemic lupus erythematosus	0.000279	0.011	CcSEcCtD
Drospirenone—PGR—lung—systemic lupus erythematosus	0.000272	0.0183	CbGeAlD
Drospirenone—NR3C2—nervous system—systemic lupus erythematosus	0.00027	0.0182	CbGeAlD
Drospirenone—BCHE—skin of body—systemic lupus erythematosus	0.000263	0.0178	CbGeAlD
Drospirenone—AR—lymphoid tissue—systemic lupus erythematosus	0.000262	0.0177	CbGeAlD
Drospirenone—NR3C2—central nervous system—systemic lupus erythematosus	0.00026	0.0176	CbGeAlD
Drospirenone—PGR—nervous system—systemic lupus erythematosus	0.000251	0.0169	CbGeAlD
Drospirenone—Migraine—Leflunomide—systemic lupus erythematosus	0.000251	0.0099	CcSEcCtD
Drospirenone—AR—tendon—systemic lupus erythematosus	0.000246	0.0166	CbGeAlD
Drospirenone—PGR—central nervous system—systemic lupus erythematosus	0.000242	0.0163	CbGeAlD
Drospirenone—Embolism—Methotrexate—systemic lupus erythematosus	0.000233	0.0092	CcSEcCtD
Drospirenone—Breast disorder—Leflunomide—systemic lupus erythematosus	0.000231	0.00909	CcSEcCtD
Drospirenone—PTGS2—connective tissue—systemic lupus erythematosus	0.000225	0.0152	CbGeAlD
Drospirenone—AR—lung—systemic lupus erythematosus	0.000216	0.0146	CbGeAlD
Drospirenone—PTGS2—skin of body—systemic lupus erythematosus	0.000203	0.0137	CbGeAlD
Drospirenone—AR—nervous system—systemic lupus erythematosus	0.0002	0.0135	CbGeAlD
Drospirenone—Cerebrovascular accident—Mycophenolate mofetil—systemic lupus erythematosus	0.000196	0.00773	CcSEcCtD
Drospirenone—BCHE—bone marrow—systemic lupus erythematosus	0.000194	0.0131	CbGeAlD
Drospirenone—Affect lability—Cyclosporine—systemic lupus erythematosus	0.000194	0.00764	CcSEcCtD
Drospirenone—Migraine—Cyclosporine—systemic lupus erythematosus	0.000194	0.00764	CcSEcCtD
Drospirenone—AR—central nervous system—systemic lupus erythematosus	0.000193	0.013	CbGeAlD
Drospirenone—PTGS2—kidney—systemic lupus erythematosus	0.000191	0.0129	CbGeAlD
Drospirenone—Affect lability—Mycophenolate mofetil—systemic lupus erythematosus	0.000189	0.00745	CcSEcCtD
Drospirenone—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.000189	0.159	CbGdCrCtD
Drospirenone—Haemoglobin—Azathioprine—systemic lupus erythematosus	0.000188	0.0074	CcSEcCtD
Drospirenone—Haemorrhage—Azathioprine—systemic lupus erythematosus	0.000187	0.00737	CcSEcCtD
Drospirenone—Mood swings—Cyclosporine—systemic lupus erythematosus	0.000187	0.00735	CcSEcCtD
Drospirenone—Medrysone—NR3C1—systemic lupus erythematosus	0.000186	0.163	CrCbGaD
Drospirenone—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.000186	0.156	CbGdCrCtD
Drospirenone—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.000186	0.156	CbGdCrCtD
Drospirenone—Mood swings—Mycophenolate mofetil—systemic lupus erythematosus	0.000182	0.00717	CcSEcCtD
Drospirenone—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.000182	0.153	CbGdCrCtD
Drospirenone—Flurandrenolide—NR3C1—systemic lupus erythematosus	0.00018	0.157	CrCbGaD
Drospirenone—Breast disorder—Cyclosporine—systemic lupus erythematosus	0.000178	0.00701	CcSEcCtD
Drospirenone—Haemoglobin—Leflunomide—systemic lupus erythematosus	0.000177	0.00699	CcSEcCtD
Drospirenone—Erythema multiforme—Azathioprine—systemic lupus erythematosus	0.000177	0.00696	CcSEcCtD
Drospirenone—Haemorrhage—Leflunomide—systemic lupus erythematosus	0.000176	0.00696	CcSEcCtD
Drospirenone—Affect lability—Prednisolone—systemic lupus erythematosus	0.000176	0.00695	CcSEcCtD
Drospirenone—BCHE—lung—systemic lupus erythematosus	0.000176	0.0119	CbGeAlD
Drospirenone—Affect lability—Hydrocortisone—systemic lupus erythematosus	0.000172	0.00679	CcSEcCtD
Drospirenone—Cortisone acetate—NR3C1—systemic lupus erythematosus	0.000171	0.149	CrCbGaD
Drospirenone—Mood swings—Prednisolone—systemic lupus erythematosus	0.00017	0.00669	CcSEcCtD
Drospirenone—Erythema multiforme—Leflunomide—systemic lupus erythematosus	0.000167	0.00658	CcSEcCtD
Drospirenone—Mood swings—Hydrocortisone—systemic lupus erythematosus	0.000166	0.00653	CcSEcCtD
Drospirenone—Megestrol acetate—NR3C1—systemic lupus erythematosus	0.000165	0.144	CrCbGaD
Drospirenone—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000164	0.0111	CbGeAlD
Drospirenone—BCHE—nervous system—systemic lupus erythematosus	0.000163	0.011	CbGeAlD
Drospirenone—Affect lability—Triamcinolone—systemic lupus erythematosus	0.000162	0.00639	CcSEcCtD
Drospirenone—Affect lability—Methylprednisolone—systemic lupus erythematosus	0.000162	0.00638	CcSEcCtD
Drospirenone—BCHE—central nervous system—systemic lupus erythematosus	0.000157	0.0106	CbGeAlD
Drospirenone—Mood swings—Triamcinolone—systemic lupus erythematosus	0.000156	0.00615	CcSEcCtD
Drospirenone—Mood swings—Methylprednisolone—systemic lupus erythematosus	0.000156	0.00614	CcSEcCtD
Drospirenone—Mental disorder—Leflunomide—systemic lupus erythematosus	0.000155	0.00609	CcSEcCtD
Drospirenone—PTGS2—tendon—systemic lupus erythematosus	0.000155	0.0104	CbGeAlD
Drospirenone—Depression—Cyclosporine—systemic lupus erythematosus	0.000151	0.00596	CcSEcCtD
Drospirenone—PTGS2—bone marrow—systemic lupus erythematosus	0.00015	0.0101	CbGeAlD
Drospirenone—Acute coronary syndrome—Cyclosporine—systemic lupus erythematosus	0.00015	0.0059	CcSEcCtD
Drospirenone—Myocardial infarction—Cyclosporine—systemic lupus erythematosus	0.000149	0.00586	CcSEcCtD
Drospirenone—Breast disorder—Methylprednisolone—systemic lupus erythematosus	0.000149	0.00586	CcSEcCtD
Drospirenone—Depression—Mycophenolate mofetil—systemic lupus erythematosus	0.000148	0.00582	CcSEcCtD
Drospirenone—Affect lability—Betamethasone—systemic lupus erythematosus	0.000147	0.0058	CcSEcCtD
Drospirenone—Affect lability—Dexamethasone—systemic lupus erythematosus	0.000147	0.0058	CcSEcCtD
Drospirenone—Migraine—Dexamethasone—systemic lupus erythematosus	0.000147	0.0058	CcSEcCtD
Drospirenone—Migraine—Betamethasone—systemic lupus erythematosus	0.000147	0.0058	CcSEcCtD
Drospirenone—Acute coronary syndrome—Mycophenolate mofetil—systemic lupus erythematosus	0.000146	0.00575	CcSEcCtD
Drospirenone—Myocardial infarction—Mycophenolate mofetil—systemic lupus erythematosus	0.000145	0.00572	CcSEcCtD
Drospirenone—Mood swings—Betamethasone—systemic lupus erythematosus	0.000142	0.00558	CcSEcCtD
Drospirenone—Mood swings—Dexamethasone—systemic lupus erythematosus	0.000142	0.00558	CcSEcCtD
Drospirenone—Nausea—Dapsone—systemic lupus erythematosus	0.000139	0.0055	CcSEcCtD
Drospirenone—AR—Nuclear Receptors—RXRA—systemic lupus erythematosus	0.000139	0.0106	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic lupus erythematosus	0.000138	0.00542	CcSEcCtD
Drospirenone—Haemoglobin—Cyclosporine—systemic lupus erythematosus	0.000137	0.0054	CcSEcCtD
Drospirenone—Haemorrhage—Cyclosporine—systemic lupus erythematosus	0.000136	0.00537	CcSEcCtD
Drospirenone—Acute coronary syndrome—Prednisolone—systemic lupus erythematosus	0.000136	0.00536	CcSEcCtD
Drospirenone—PTGS2—lung—systemic lupus erythematosus	0.000136	0.00914	CbGeAlD
Drospirenone—Myocardial infarction—Prednisolone—systemic lupus erythematosus	0.000135	0.00533	CcSEcCtD
Drospirenone—Haemoglobin—Mycophenolate mofetil—systemic lupus erythematosus	0.000134	0.00526	CcSEcCtD
Drospirenone—Acute coronary syndrome—Hydrocortisone—systemic lupus erythematosus	0.000133	0.00524	CcSEcCtD
Drospirenone—Haemorrhage—Mycophenolate mofetil—systemic lupus erythematosus	0.000133	0.00524	CcSEcCtD
Drospirenone—Myocardial infarction—Hydrocortisone—systemic lupus erythematosus	0.000132	0.00521	CcSEcCtD
Drospirenone—PGR—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.00013	0.00996	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic lupus erythematosus	0.00013	0.00512	CcSEcCtD
Drospirenone—Skin disorder—Azathioprine—systemic lupus erythematosus	0.000129	0.00508	CcSEcCtD
Drospirenone—Affect lability—Prednisone—systemic lupus erythematosus	0.000128	0.00505	CcSEcCtD
Drospirenone—PGR—Validated nuclear estrogen receptor alpha network—PRL—systemic lupus erythematosus	0.000126	0.00964	CbGpPWpGaD
Drospirenone—AR—Nuclear Receptors—VDR—systemic lupus erythematosus	0.000126	0.0096	CbGpPWpGaD
Drospirenone—PTGS2—nervous system—systemic lupus erythematosus	0.000126	0.00846	CbGeAlD
Drospirenone—Acute coronary syndrome—Triamcinolone—systemic lupus erythematosus	0.000125	0.00493	CcSEcCtD
Drospirenone—Acute coronary syndrome—Methylprednisolone—systemic lupus erythematosus	0.000125	0.00492	CcSEcCtD
Drospirenone—Haemoglobin—Prednisolone—systemic lupus erythematosus	0.000125	0.00491	CcSEcCtD
Drospirenone—Myocardial infarction—Triamcinolone—systemic lupus erythematosus	0.000124	0.00491	CcSEcCtD
Drospirenone—Myocardial infarction—Methylprednisolone—systemic lupus erythematosus	0.000124	0.00489	CcSEcCtD
Drospirenone—Haemorrhage—Prednisolone—systemic lupus erythematosus	0.000124	0.00489	CcSEcCtD
Drospirenone—Angiopathy—Cyclosporine—systemic lupus erythematosus	0.000124	0.00487	CcSEcCtD
Drospirenone—Mood swings—Prednisone—systemic lupus erythematosus	0.000123	0.00486	CcSEcCtD
Drospirenone—Nervous system disorder—Leflunomide—systemic lupus erythematosus	0.000123	0.00485	CcSEcCtD
Drospirenone—Skin disorder—Leflunomide—systemic lupus erythematosus	0.000122	0.0048	CcSEcCtD
Drospirenone—Haemoglobin—Hydrocortisone—systemic lupus erythematosus	0.000122	0.0048	CcSEcCtD
Drospirenone—Haemorrhage—Hydrocortisone—systemic lupus erythematosus	0.000121	0.00477	CcSEcCtD
Drospirenone—PTGS2—central nervous system—systemic lupus erythematosus	0.000121	0.00815	CbGeAlD
Drospirenone—Angiopathy—Mycophenolate mofetil—systemic lupus erythematosus	0.000121	0.00475	CcSEcCtD
Drospirenone—Mental disorder—Cyclosporine—systemic lupus erythematosus	0.000119	0.0047	CcSEcCtD
Drospirenone—PGR—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	0.000117	0.00896	CbGpPWpGaD
Drospirenone—Mental disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000116	0.00459	CcSEcCtD
Drospirenone—PGR—Nuclear Receptors—PPARG—systemic lupus erythematosus	0.000115	0.00878	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.000115	0.00452	CcSEcCtD
Drospirenone—Haemoglobin—Triamcinolone—systemic lupus erythematosus	0.000115	0.00452	CcSEcCtD
Drospirenone—Haemoglobin—Methylprednisolone—systemic lupus erythematosus	0.000114	0.00451	CcSEcCtD
Drospirenone—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.000114	0.0958	CbGdCrCtD
Drospirenone—Haemorrhage—Triamcinolone—systemic lupus erythematosus	0.000114	0.00449	CcSEcCtD
Drospirenone—Haemorrhage—Methylprednisolone—systemic lupus erythematosus	0.000114	0.00448	CcSEcCtD
Drospirenone—Acute coronary syndrome—Dexamethasone—systemic lupus erythematosus	0.000114	0.00448	CcSEcCtD
Drospirenone—Acute coronary syndrome—Betamethasone—systemic lupus erythematosus	0.000114	0.00448	CcSEcCtD
Drospirenone—AR—Nuclear Receptors—NR3C1—systemic lupus erythematosus	0.000113	0.00864	CbGpPWpGaD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUNB—systemic lupus erythematosus	0.000113	0.00863	CbGpPWpGaD
Drospirenone—Myocardial infarction—Betamethasone—systemic lupus erythematosus	0.000113	0.00445	CcSEcCtD
Drospirenone—Myocardial infarction—Dexamethasone—systemic lupus erythematosus	0.000113	0.00445	CcSEcCtD
Drospirenone—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000112	0.0943	CbGdCrCtD
Drospirenone—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000112	0.0943	CbGdCrCtD
Drospirenone—Cerebrovascular accident—Methotrexate—systemic lupus erythematosus	0.000111	0.00438	CcSEcCtD
Drospirenone—AR—Nuclear Receptor transcription pathway—RXRA—systemic lupus erythematosus	0.00011	0.00837	CbGpPWpGaD
Drospirenone—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.00011	0.0921	CbGdCrCtD
Drospirenone—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.000108	0.00427	CcSEcCtD
Drospirenone—AR—Regulation of Androgen receptor activity—RXRA—systemic lupus erythematosus	0.000106	0.00812	CbGpPWpGaD
Drospirenone—Mental disorder—Hydrocortisone—systemic lupus erythematosus	0.000106	0.00418	CcSEcCtD
Drospirenone—AR—SIDS Susceptibility Pathways—C4A—systemic lupus erythematosus	0.000106	0.00806	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—C4B—systemic lupus erythematosus	0.000106	0.00806	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—systemic lupus erythematosus	0.000105	0.00805	CbGpPWpGaD
Drospirenone—Haemoglobin—Dexamethasone—systemic lupus erythematosus	0.000104	0.0041	CcSEcCtD
Drospirenone—Haemoglobin—Betamethasone—systemic lupus erythematosus	0.000104	0.0041	CcSEcCtD
Drospirenone—Haemorrhage—Betamethasone—systemic lupus erythematosus	0.000103	0.00408	CcSEcCtD
Drospirenone—Haemorrhage—Dexamethasone—systemic lupus erythematosus	0.000103	0.00408	CcSEcCtD
Drospirenone—Angiopathy—Methylprednisolone—systemic lupus erythematosus	0.000103	0.00407	CcSEcCtD
Drospirenone—Mood swings—Methotrexate—systemic lupus erythematosus	0.000103	0.00406	CcSEcCtD
Drospirenone—PTGS2—Overview of nanoparticle effects—CRP—systemic lupus erythematosus	0.000103	0.00786	CbGpPWpGaD
Drospirenone—Spironolactone—NR3C1—systemic lupus erythematosus	0.000103	0.0896	CrCbGaD
Drospirenone—PTGS2—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	0.000101	0.00774	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.0001	0.00395	CcSEcCtD
Drospirenone—Depression—Prednisone—systemic lupus erythematosus	0.0001	0.00394	CcSEcCtD
Drospirenone—Mental disorder—Methylprednisolone—systemic lupus erythematosus	9.96e-05	0.00393	CcSEcCtD
Drospirenone—AR—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	9.93e-05	0.00758	CbGpPWpGaD
Drospirenone—Acute coronary syndrome—Prednisone—systemic lupus erythematosus	9.89e-05	0.0039	CcSEcCtD
Drospirenone—Myocardial infarction—Prednisone—systemic lupus erythematosus	9.83e-05	0.00388	CcSEcCtD
Drospirenone—Breast disorder—Methotrexate—systemic lupus erythematosus	9.83e-05	0.00388	CcSEcCtD
Drospirenone—PGR—Ovarian Infertility Genes—CDKN1B—systemic lupus erythematosus	9.83e-05	0.00751	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	9.78e-05	0.00385	CcSEcCtD
Drospirenone—Medroxyprogesterone Acetate—NR3C1—systemic lupus erythematosus	9.61e-05	0.0839	CrCbGaD
Drospirenone—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	9.49e-05	0.00374	CcSEcCtD
Drospirenone—PGR—Cellular roles of Anthrax toxin—TNF—systemic lupus erythematosus	9.46e-05	0.00722	CbGpPWpGaD
Drospirenone—Skin disorder—Cyclosporine—systemic lupus erythematosus	9.4e-05	0.0037	CcSEcCtD
Drospirenone—Angiopathy—Betamethasone—systemic lupus erythematosus	9.38e-05	0.0037	CcSEcCtD
Drospirenone—Angiopathy—Dexamethasone—systemic lupus erythematosus	9.38e-05	0.0037	CcSEcCtD
Drospirenone—PGR—Validated nuclear estrogen receptor alpha network—C3—systemic lupus erythematosus	9.35e-05	0.00714	CbGpPWpGaD
Drospirenone—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	9.26e-05	0.00365	CcSEcCtD
Drospirenone—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	9.17e-05	0.00361	CcSEcCtD
Drospirenone—PGR—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	9.09e-05	0.00694	CbGpPWpGaD
Drospirenone—Haemoglobin—Prednisone—systemic lupus erythematosus	9.05e-05	0.00357	CcSEcCtD
Drospirenone—Haemorrhage—Prednisone—systemic lupus erythematosus	9.01e-05	0.00355	CcSEcCtD
Drospirenone—AR—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	8.94e-05	0.00683	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	8.91e-05	0.00351	CcSEcCtD
Drospirenone—AR—Nuclear Receptors—PPARG—systemic lupus erythematosus	8.76e-05	0.00669	CbGpPWpGaD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—systemic lupus erythematosus	8.73e-05	0.00666	CbGpPWpGaD
Drospirenone—AR—Regulation of Androgen receptor activity—NR3C1—systemic lupus erythematosus	8.67e-05	0.00662	CbGpPWpGaD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—systemic lupus erythematosus	8.49e-05	0.00648	CbGpPWpGaD
Drospirenone—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	8.43e-05	0.00332	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	8.37e-05	0.0033	CcSEcCtD
Drospirenone—Depression—Methotrexate—systemic lupus erythematosus	8.36e-05	0.0033	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	8.35e-05	0.00329	CcSEcCtD
Drospirenone—Skin disorder—Hydrocortisone—systemic lupus erythematosus	8.35e-05	0.00329	CcSEcCtD
Drospirenone—Angiopathy—Prednisone—systemic lupus erythematosus	8.17e-05	0.00322	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	8.15e-05	0.00321	CcSEcCtD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—systemic lupus erythematosus	8.11e-05	0.0062	CbGpPWpGaD
Drospirenone—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	7.92e-05	0.00312	CcSEcCtD
Drospirenone—Mental disorder—Prednisone—systemic lupus erythematosus	7.89e-05	0.00311	CcSEcCtD
Drospirenone—Nausea—Azathioprine—systemic lupus erythematosus	7.89e-05	0.00311	CcSEcCtD
Drospirenone—Skin disorder—Methylprednisolone—systemic lupus erythematosus	7.85e-05	0.00309	CcSEcCtD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—systemic lupus erythematosus	7.78e-05	0.00594	CbGpPWpGaD
Drospirenone—Haemoglobin—Methotrexate—systemic lupus erythematosus	7.57e-05	0.00298	CcSEcCtD
Drospirenone—Haemorrhage—Methotrexate—systemic lupus erythematosus	7.53e-05	0.00297	CcSEcCtD
Drospirenone—Nausea—Leflunomide—systemic lupus erythematosus	7.45e-05	0.00294	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	7.42e-05	0.00293	CcSEcCtD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUNB—systemic lupus erythematosus	7.31e-05	0.00558	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic lupus erythematosus	7.26e-05	0.00554	CbGpPWpGaD
Drospirenone—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	7.21e-05	0.00284	CcSEcCtD
Drospirenone—Nervous system disorder—Betamethasone—systemic lupus erythematosus	7.21e-05	0.00284	CcSEcCtD
Drospirenone—Erythema multiforme—Methotrexate—systemic lupus erythematosus	7.12e-05	0.00281	CcSEcCtD
Drospirenone—BCHE—Peptide hormone metabolism—ACE—systemic lupus erythematosus	7.1e-05	0.00543	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—CXCL12—systemic lupus erythematosus	6.98e-05	0.00533	CbGpPWpGaD
Drospirenone—AR—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	6.92e-05	0.00529	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—VDR—systemic lupus erythematosus	6.86e-05	0.00524	CbGpPWpGaD
Drospirenone—Angiopathy—Methotrexate—systemic lupus erythematosus	6.83e-05	0.00269	CcSEcCtD
Drospirenone—Hydrocortisone—NR3C1—systemic lupus erythematosus	6.81e-05	0.0595	CrCbGaD
Drospirenone—PTGS2—Spinal Cord Injury—TNFSF13—systemic lupus erythematosus	6.76e-05	0.00516	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—SNRPD1—systemic lupus erythematosus	6.75e-05	0.00515	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—systemic lupus erythematosus	6.67e-05	0.0051	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	6.63e-05	0.00261	CcSEcCtD
Drospirenone—Mental disorder—Methotrexate—systemic lupus erythematosus	6.59e-05	0.0026	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	6.34e-05	0.0025	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	6.34e-05	0.0025	CcSEcCtD
Drospirenone—PGR—Signaling by ERBB4—PRL—systemic lupus erythematosus	6.32e-05	0.00482	CbGpPWpGaD
Drospirenone—Nervous system disorder—Prednisone—systemic lupus erythematosus	6.28e-05	0.00247	CcSEcCtD
Drospirenone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—systemic lupus erythematosus	6.24e-05	0.00476	CbGpPWpGaD
Drospirenone—Skin disorder—Prednisone—systemic lupus erythematosus	6.22e-05	0.00245	CcSEcCtD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—systemic lupus erythematosus	6.17e-05	0.00472	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—MTA2—systemic lupus erythematosus	6.1e-05	0.00466	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—ETS1—systemic lupus erythematosus	5.99e-05	0.00458	CbGpPWpGaD
Drospirenone—AR—Notch-mediated HES/HEY network—CD4—systemic lupus erythematosus	5.86e-05	0.00447	CbGpPWpGaD
Drospirenone—AR—FOXA1 transcription factor network—CDKN1B—systemic lupus erythematosus	5.81e-05	0.00443	CbGpPWpGaD
Drospirenone—Nausea—Cyclosporine—systemic lupus erythematosus	5.75e-05	0.00227	CcSEcCtD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic lupus erythematosus	5.64e-05	0.00431	CbGpPWpGaD
Drospirenone—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	5.61e-05	0.00221	CcSEcCtD
Drospirenone—AR—Integrated Breast Cancer Pathway—GADD45A—systemic lupus erythematosus	5.57e-05	0.00425	CbGpPWpGaD
Drospirenone—Progesterone—NR3C1—systemic lupus erythematosus	5.55e-05	0.0485	CrCbGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	5.54e-05	0.00218	CcSEcCtD
Drospirenone—AR—SIDS Susceptibility Pathways—IL1RN—systemic lupus erythematosus	5.52e-05	0.00421	CbGpPWpGaD
Drospirenone—AR—Notch-mediated HES/HEY network—CDKN1B—systemic lupus erythematosus	5.51e-05	0.00421	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—systemic lupus erythematosus	5.49e-05	0.00419	CbGpPWpGaD
Drospirenone—PTGS2—S1P1 pathway—VEGFA—systemic lupus erythematosus	5.43e-05	0.00415	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—systemic lupus erythematosus	5.25e-05	0.00401	CbGpPWpGaD
Drospirenone—Nervous system disorder—Methotrexate—systemic lupus erythematosus	5.24e-05	0.00207	CcSEcCtD
Drospirenone—Nausea—Prednisolone—systemic lupus erythematosus	5.23e-05	0.00206	CcSEcCtD
Drospirenone—Skin disorder—Methotrexate—systemic lupus erythematosus	5.19e-05	0.00205	CcSEcCtD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—systemic lupus erythematosus	5.13e-05	0.00392	CbGpPWpGaD
Drospirenone—Nausea—Hydrocortisone—systemic lupus erythematosus	5.11e-05	0.00201	CcSEcCtD
Drospirenone—AR—FOXA1 transcription factor network—EP300—systemic lupus erythematosus	5.1e-05	0.00389	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—JAK1—systemic lupus erythematosus	5.05e-05	0.00386	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—systemic lupus erythematosus	5.03e-05	0.00384	CbGpPWpGaD
Drospirenone—PGR—Validated nuclear estrogen receptor alpha network—EP300—systemic lupus erythematosus	4.96e-05	0.00379	CbGpPWpGaD
Drospirenone—AR—Notch-mediated HES/HEY network—EP300—systemic lupus erythematosus	4.84e-05	0.00369	CbGpPWpGaD
Drospirenone—Norethindrone—ALB—systemic lupus erythematosus	4.82e-05	0.0421	CrCbGaD
Drospirenone—Nausea—Triamcinolone—systemic lupus erythematosus	4.81e-05	0.0019	CcSEcCtD
Drospirenone—Nausea—Methylprednisolone—systemic lupus erythematosus	4.8e-05	0.00189	CcSEcCtD
Drospirenone—NR3C2—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	4.66e-05	0.00356	CbGpPWpGaD
Drospirenone—PTGS2—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	4.66e-05	0.00356	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	4.62e-05	0.00182	CcSEcCtD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	4.61e-05	0.00352	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—FCGR2A—systemic lupus erythematosus	4.6e-05	0.00351	CbGpPWpGaD
Drospirenone—Methyltestosterone—ALB—systemic lupus erythematosus	4.57e-05	0.0399	CrCbGaD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—systemic lupus erythematosus	4.56e-05	0.00348	CbGpPWpGaD
Drospirenone—AR—Regulation of Androgen receptor activity—EP300—systemic lupus erythematosus	4.39e-05	0.00335	CbGpPWpGaD
Drospirenone—Nausea—Betamethasone—systemic lupus erythematosus	4.36e-05	0.00172	CcSEcCtD
Drospirenone—Nausea—Dexamethasone—systemic lupus erythematosus	4.36e-05	0.00172	CcSEcCtD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	4.35e-05	0.00332	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—TNFSF13—systemic lupus erythematosus	4.12e-05	0.00315	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—SNRPD1—systemic lupus erythematosus	4.11e-05	0.00314	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	4.08e-05	0.00312	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—systemic lupus erythematosus	4.04e-05	0.00309	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—SNRPB—systemic lupus erythematosus	3.99e-05	0.00305	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	3.95e-05	0.00302	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—CD80—systemic lupus erythematosus	3.94e-05	0.00301	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—GADD45A—systemic lupus erythematosus	3.9e-05	0.00298	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—JAK1—systemic lupus erythematosus	3.87e-05	0.00296	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	3.81e-05	0.00291	CbGpPWpGaD
Drospirenone—Nausea—Prednisone—systemic lupus erythematosus	3.8e-05	0.0015	CcSEcCtD
Drospirenone—PTGS2—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	3.76e-05	0.00287	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MTA2—systemic lupus erythematosus	3.72e-05	0.00284	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—VDR—systemic lupus erythematosus	3.7e-05	0.00282	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	3.65e-05	0.00279	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—systemic lupus erythematosus	3.33e-05	0.00255	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	3.33e-05	0.00254	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—TYK2—systemic lupus erythematosus	3.32e-05	0.00254	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—systemic lupus erythematosus	3.32e-05	0.00253	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—systemic lupus erythematosus	3.29e-05	0.00251	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	3.22e-05	0.00246	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—HIST2H2AC—systemic lupus erythematosus	3.21e-05	0.00245	CbGpPWpGaD
Drospirenone—Nausea—Methotrexate—systemic lupus erythematosus	3.18e-05	0.00125	CcSEcCtD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—systemic lupus erythematosus	3.16e-05	0.00241	CbGpPWpGaD
Drospirenone—AR—Gene Expression—SNRPD1—systemic lupus erythematosus	3.13e-05	0.00239	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—systemic lupus erythematosus	3.13e-05	0.00239	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	3.12e-05	0.00239	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—CDKN1A—systemic lupus erythematosus	3.05e-05	0.00233	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	3.02e-05	0.00231	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	3.01e-05	0.0023	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	2.97e-05	0.00227	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—systemic lupus erythematosus	2.95e-05	0.00225	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—EP300—systemic lupus erythematosus	2.9e-05	0.00222	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	2.84e-05	0.00217	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MTA2—systemic lupus erythematosus	2.83e-05	0.00216	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	2.83e-05	0.00216	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—CDKN1B—systemic lupus erythematosus	2.83e-05	0.00216	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—F2—systemic lupus erythematosus	2.79e-05	0.00213	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL4—systemic lupus erythematosus	2.76e-05	0.00211	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MAN2A1—systemic lupus erythematosus	2.71e-05	0.00207	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	2.68e-05	0.00205	CbGpPWpGaD
Drospirenone—Testosterone—ALB—systemic lupus erythematosus	2.65e-05	0.0232	CrCbGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	2.65e-05	0.00203	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—CDKN1A—systemic lupus erythematosus	2.61e-05	0.00199	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	2.58e-05	0.00197	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—TNFSF13—systemic lupus erythematosus	2.51e-05	0.00192	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	2.5e-05	0.00191	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	2.49e-05	0.0019	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	2.48e-05	0.0019	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—SNRPB—systemic lupus erythematosus	2.43e-05	0.00186	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	2.31e-05	0.00177	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	2.3e-05	0.00175	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TLR4—systemic lupus erythematosus	2.29e-05	0.00175	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—VDR—systemic lupus erythematosus	2.25e-05	0.00172	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—JUNB—systemic lupus erythematosus	2.24e-05	0.00171	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	2.19e-05	0.00167	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	2.16e-05	0.00165	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—systemic lupus erythematosus	2.15e-05	0.00164	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—CD4—systemic lupus erythematosus	2.12e-05	0.00162	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	2.11e-05	0.00161	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	2.03e-05	0.00155	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—CDKN1B—systemic lupus erythematosus	1.99e-05	0.00152	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—RXRA—systemic lupus erythematosus	1.97e-05	0.0015	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CCL2—systemic lupus erythematosus	1.96e-05	0.0015	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—HIST2H2AC—systemic lupus erythematosus	1.95e-05	0.00149	CbGpPWpGaD
Drospirenone—AR—Gene Expression—TNFSF13—systemic lupus erythematosus	1.91e-05	0.00146	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	1.9e-05	0.00145	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	1.89e-05	0.00145	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1.89e-05	0.00145	CbGpPWpGaD
Drospirenone—AR—Gene Expression—SNRPB—systemic lupus erythematosus	1.85e-05	0.00142	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	1.85e-05	0.00141	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—CDKN1A—systemic lupus erythematosus	1.84e-05	0.0014	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	1.8e-05	0.00137	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	1.8e-05	0.00137	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.79e-05	0.00137	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—VDR—systemic lupus erythematosus	1.78e-05	0.00136	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	1.75e-05	0.00134	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—EP300—systemic lupus erythematosus	1.75e-05	0.00133	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	1.73e-05	0.00132	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—VDR—systemic lupus erythematosus	1.72e-05	0.00131	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IFNG—systemic lupus erythematosus	1.67e-05	0.00128	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.66e-05	0.00126	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—IL6—systemic lupus erythematosus	1.63e-05	0.00124	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—NR3C1—systemic lupus erythematosus	1.6e-05	0.00122	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.58e-05	0.0012	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	1.57e-05	0.0012	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	1.54e-05	0.00118	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	1.52e-05	0.00116	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	1.5e-05	0.00115	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.49e-05	0.00114	CbGpPWpGaD
Drospirenone—AR—Gene Expression—HIST2H2AC—systemic lupus erythematosus	1.49e-05	0.00114	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL2—systemic lupus erythematosus	1.48e-05	0.00113	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—MMP9—systemic lupus erythematosus	1.4e-05	0.00107	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TLR9—systemic lupus erythematosus	1.39e-05	0.00106	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.37e-05	0.00105	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	1.37e-05	0.00104	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—JUNB—systemic lupus erythematosus	1.37e-05	0.00104	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.34e-05	0.00103	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—ACE—systemic lupus erythematosus	1.34e-05	0.00102	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.33e-05	0.00102	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.28e-05	0.000976	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.27e-05	0.00097	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—PPARG—systemic lupus erythematosus	1.24e-05	0.000948	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CSK—systemic lupus erythematosus	1.24e-05	0.000945	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	1.21e-05	0.000926	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—RXRA—systemic lupus erythematosus	1.2e-05	0.000914	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	1.2e-05	0.000913	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	1.16e-05	0.000884	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NCF2—systemic lupus erythematosus	1.13e-05	0.000864	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—LYN—systemic lupus erythematosus	1.12e-05	0.000859	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.1e-05	0.000842	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	1.1e-05	0.000842	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—VDR—systemic lupus erythematosus	1.08e-05	0.000828	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TNF—systemic lupus erythematosus	1.08e-05	0.000825	CbGpPWpGaD
Drospirenone—PTGS2—Disease—XRCC6—systemic lupus erythematosus	1.08e-05	0.000823	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NAT2—systemic lupus erythematosus	1.06e-05	0.000807	CbGpPWpGaD
Drospirenone—AR—Gene Expression—JUNB—systemic lupus erythematosus	1.04e-05	0.000795	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.03e-05	0.000788	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—NR3C1—systemic lupus erythematosus	9.76e-06	0.000745	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	9.52e-06	0.000727	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	9.15e-06	0.000699	CbGpPWpGaD
Drospirenone—AR—Gene Expression—RXRA—systemic lupus erythematosus	9.12e-06	0.000696	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	9.06e-06	0.000692	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL12—systemic lupus erythematosus	9.05e-06	0.000691	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—JUNB—systemic lupus erythematosus	8.88e-06	0.000678	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	8.72e-06	0.000666	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	8.58e-06	0.000655	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.44e-06	0.000644	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	8.4e-06	0.000641	CbGpPWpGaD
Drospirenone—AR—Gene Expression—VDR—systemic lupus erythematosus	8.26e-06	0.000631	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PRL—systemic lupus erythematosus	8.18e-06	0.000625	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	7.94e-06	0.000607	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	7.87e-06	0.000601	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—F2—systemic lupus erythematosus	7.86e-06	0.0006	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CSK—systemic lupus erythematosus	7.74e-06	0.000591	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—PPARG—systemic lupus erythematosus	7.56e-06	0.000577	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	7.55e-06	0.000577	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NR3C1—systemic lupus erythematosus	7.43e-06	0.000568	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	7.35e-06	0.000561	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD247—systemic lupus erythematosus	7.28e-06	0.000556	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	7.27e-06	0.000555	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NCF2—systemic lupus erythematosus	7.08e-06	0.000541	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CCL2—systemic lupus erythematosus	7e-06	0.000535	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.61e-06	0.000505	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—JAK1—systemic lupus erythematosus	6.54e-06	0.0005	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCR5—systemic lupus erythematosus	6.2e-06	0.000474	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.11e-06	0.000467	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—C3—systemic lupus erythematosus	6.06e-06	0.000463	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—RXRA—systemic lupus erythematosus	5.92e-06	0.000452	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.78e-06	0.000441	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PPARG—systemic lupus erythematosus	5.76e-06	0.00044	CbGpPWpGaD
Drospirenone—PTGS2—Disease—JUNB—systemic lupus erythematosus	5.56e-06	0.000424	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.49e-06	0.00042	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—F2—systemic lupus erythematosus	5.32e-06	0.000406	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.2e-06	0.000397	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PRL—systemic lupus erythematosus	5.12e-06	0.000391	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CD80—systemic lupus erythematosus	5.1e-06	0.00039	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL2—systemic lupus erythematosus	4.74e-06	0.000362	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TYK2—systemic lupus erythematosus	4.31e-06	0.000329	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOS3—systemic lupus erythematosus	4.23e-06	0.000323	CbGpPWpGaD
Drospirenone—PTGS2—Disease—JAK1—systemic lupus erythematosus	4.09e-06	0.000313	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	4.08e-06	0.000311	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CCR5—systemic lupus erythematosus	3.88e-06	0.000296	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.78e-06	0.000289	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPARG—systemic lupus erythematosus	3.74e-06	0.000286	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.66e-06	0.00028	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL2—systemic lupus erythematosus	3.58e-06	0.000274	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MMP9—systemic lupus erythematosus	3.39e-06	0.000259	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.38e-06	0.000258	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALB—systemic lupus erythematosus	3.36e-06	0.000257	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NOS3—systemic lupus erythematosus	3.22e-06	0.000246	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EP300—systemic lupus erythematosus	3.21e-06	0.000246	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD80—systemic lupus erythematosus	3.19e-06	0.000244	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.04e-06	0.000233	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTGS2—systemic lupus erythematosus	2.94e-06	0.000225	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.79e-06	0.000213	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TYK2—systemic lupus erythematosus	2.69e-06	0.000206	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS3—systemic lupus erythematosus	2.64e-06	0.000202	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	2.57e-06	0.000197	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—EP300—systemic lupus erythematosus	2.45e-06	0.000187	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD4—systemic lupus erythematosus	2.44e-06	0.000186	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALB—systemic lupus erythematosus	2.31e-06	0.000177	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	2.29e-06	0.000175	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	2.21e-06	0.000169	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	2.11e-06	0.000161	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6—systemic lupus erythematosus	2.11e-06	0.000161	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EP300—systemic lupus erythematosus	2.01e-06	0.000154	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TGFB1—systemic lupus erythematosus	1.75e-06	0.000134	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—EP300—systemic lupus erythematosus	1.68e-06	0.000129	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6—systemic lupus erythematosus	1.32e-06	0.000101	CbGpPWpGaD
